(S)-2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid-D5;(S)-2-Ethoxy-4-[2-[[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid-D5; AG-EE-623-D5; Novonorm-D5; Prandin-D5;
Repaglinide-d5 is a fully characterized chemical compound used as a reference standard of API Repaglinide. The standard offered is compliant with regulatory guidelines. Repaglinide-d5 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1217709-85-7
Related products
(R)-3-methyl-1-(2-(piperidin-1-yl)phenyl)butan-1-amine
M.F.
M.W. 246.4
CAT# AR-R01364
CAS# 219921-93-4
2-Despiperidyl-2-Amino Repaglinide (M1 Metabolite)-d4
M.F.
M.W. 388.5
CAT# AR-R01366
CAS# 874908-11-9 (non-d)